C4X Discovery Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 45
Employees
  • Stock Symbol
  • C4XD
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.56
  • (As of Wednesday Closing)

C4X Discovery General Information

Description

C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Other Healthcare Technology Systems
Pharmaceuticals
Stock Exchange
LON
Primary Office
  • Manchester One
  • 53 Portland Street
  • Manchester M1 3LD
  • England, United Kingdom
+44 0161 000 0000

C4X Discovery Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

C4X Discovery Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.56 $0.57 $0.14 - $0.75 $126M 226M 341K -$0.07

C4X Discovery Financials Summary

In Thousands,
USD
TTM 31-Jan-2021 FY 2020 31-Jul-2020 FY 2019 31-Jul-2019 FY 2018 31-Jul-2018
EV 96,561 22,461 20,621 57,651
Revenue 0 0 0 9,517
EBITDA (11,206) (11,446) (17,321) (3,159)
Net Income (9,570) (9,817) (14,057) (1,529)
Total Assets 28,080 12,643 10,537 11,873
Total Debt 707 534 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

C4X Discovery Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore C4X Discovery‘s full profile, request access.

Request a free trial

C4X Discovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore C4X Discovery‘s full profile, request access.

Request a free trial

C4X Discovery Executive Team (10)

Name Title Board Seat Contact Info
Brad Hoy Chief Financial Officer, Director & Board Member
Harry Finch Ph.D Non-Executive Director
Clive Dix Ph.D Chief Executive Officer & Director
Craig Fox Ph.D Chief Scientific Officer & Director
Bhavna Hunjan Head, Corporate Strategy and Development
You’re viewing 5 of 10 executive team members. Get the full list »

C4X Discovery Board Members (7)

Name Representing Role Since
Alexander Stevenson Self Board Member 000 0000
Clive Dix Ph.D C4X Discovery Chief Executive Officer & Director 000 0000
Craig Fox Ph.D C4X Discovery Chief Scientific Officer & Director 000 0000
Eva-Lotta Allan C4X Discovery Chairman & Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

C4X Discovery Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

C4X Discovery Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore C4X Discovery‘s full profile, request access.

Request a free trial

C4X Discovery Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 11-Jul-2016 000000000000000000 Biotechnology 00000 000 00.0
Adorial 01-Mar-2016 Merger/Acquisition 00.000 Drug Discovery 00000 000 00.0
To view C4X Discovery’s complete acquisitions history, request access »